Status:
COMPLETED
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Covid19
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 is an infectious disease caused by SARS-CoV2 virus. The objective of our study is to analyze the progression and the severity of COVID-19 in patients with RA. Indeed, few data are available o...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Confirmed COVID-19 diagnosis (positive PCR or serology) in RA patients or healthy controls.
- Exclusion criteria:
- Age under 18 years old
- Suspected COVID-19 diagnosis (typical symptoms without a positive PCR or serology)
Exclusion
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04679272
Start Date
December 1 2020
End Date
February 1 2021
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Montpellier
Montpellier, France, 34295